APA

Michelis F. V., Messner H. A., Atenafu E. G., McGillis L., Lambie A., Uhm J., Alam N., Seftel M. D., Gupta V., Kuruvilla J., Lipton J. H. & Kim D. D. (20160823). Patient age, remission status and HCT-CI in a combined score are prognostic for patients with AML undergoing allogeneic hematopoietic cell transplantation in CR1 and CR2. : Bone marrow transplantation.

Chicago

Michelis F V, Messner H A, Atenafu E G, McGillis L, Lambie A, Uhm J, Alam N, Seftel M D, Gupta V, Kuruvilla J, Lipton J H and Kim D D. 20160823. Patient age, remission status and HCT-CI in a combined score are prognostic for patients with AML undergoing allogeneic hematopoietic cell transplantation in CR1 and CR2. : Bone marrow transplantation.

Harvard

Michelis F. V., Messner H. A., Atenafu E. G., McGillis L., Lambie A., Uhm J., Alam N., Seftel M. D., Gupta V., Kuruvilla J., Lipton J. H. and Kim D. D. (20160823). Patient age, remission status and HCT-CI in a combined score are prognostic for patients with AML undergoing allogeneic hematopoietic cell transplantation in CR1 and CR2. : Bone marrow transplantation.

MLA

Michelis F V, Messner H A, Atenafu E G, McGillis L, Lambie A, Uhm J, Alam N, Seftel M D, Gupta V, Kuruvilla J, Lipton J H and Kim D D. Patient age, remission status and HCT-CI in a combined score are prognostic for patients with AML undergoing allogeneic hematopoietic cell transplantation in CR1 and CR2. : Bone marrow transplantation. 20160823.